VBIO: Wolf Lisa G discloses securities transactions
By AlphaYouPublished Form 4
Wolf Lisa G
Reporting filer
Wolf Lisa G reported Exercise or conversion in Valion Bio, Inc.: 4 units of Common Stock, dated 2026-09-18. The full Form 4 contains 3 transaction entries.
- Disclosed
- Sep 24, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Wolf Lisa G | 2026-09-18 | M | Exercise or conversion | 4 | Not stated (see footnotes) | 29 | 6 days | Filed terms
|
| Common Stock | Wolf Lisa G | 2026-09-18 | F | Tax/exercise withholding | 2 | 2.12 | 27 | 6 days | Filed terms
|
| Restricted Stock Units (derivative) | Wolf Lisa G | 2026-09-18 | M | Exercise or conversion | 4 | 0 | 19 | 6 days | Filed terms
|
Common Stock
- Owner
- Wolf Lisa G
- Date
- 2026-09-18
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 4
- Price
- Not stated (see footnotes)
- Following holdings
- 29
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-18
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 4
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 29
- id: F3
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Wolf Lisa G
- Date
- 2026-09-18
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 2
- Price
- 2.12
- Following holdings
- 27
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-18
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- id: F2
- transaction Timeliness:
- transaction Shares: 2
- transaction Price Per Share: 2.12
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 27
- id: F4
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Wolf Lisa G
- Date
- 2026-09-18
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 4
- Price
- 0
- Following holdings
- 19
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F1
- transaction Date: 2026-09-18
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 4
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F3
- id: F3
- underlying Security Title: Common Stock
- underlying Security Shares: 4
- shares Owned Following Transaction: 19
- id: F4
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Wolf Lisa G: COO & CFO.
- F1: Each Restricted Stock Unit is convertible into one share of Common Stock.
- F2: The Reporting Person forfeited 2 shares of Common Stock upon vesting and settlement of 4 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's Common Stock at the time of forfeiture.
- F3: Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.
- F4: These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.